NFKB1 and metabolic dysfunction-associated steatohepatitis: NF‐κB activation has also proved effective in enhancing M1 polarization in obstructive sleep apnea (OSA), and exacerbates inflammation and fibrosis in patients with nonalcoholic steatohepatitis (NASH) by inhibiting miR‐365.24